Skip to content

Role of chemotherapy along with radiation in advanced carcinoma of cervix after induction chemotherapy in rural india

A pilot study assessing the role of induction chemotherapy followed by chemo radiation in locally advanced cervical cancer in a tertiary care hospital in central rural India - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068698
Enrollment
50
Registered
2024-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Neoadjuvent chemotherapy with inj paclitaxel and inj carboplatin: Patients with stage III and IV procceds bt giving NACT with chemotherapy drug regimen injection paclitaxel 80mg per met

Sponsors

Siddharth gupta memorial hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 year ECOG 0/1 Good renal, hepatic and CBC Women with biopsy proven squamous, adeno or adenosquamous carcinoma Stage III and IVA FIGO (2018)

Exclusion criteria

Exclusion criteria: Patients with early stage cancer stage I and II metastaic disease at presentation autoimmune disease patient who not willing for study

Design outcomes

Primary

MeasureTime frame
progression free survival in FIGO stage III and IVa patient after giving NACTTimepoint: progression free survival in FIGO stage IIIand IVa patient after giving NACT after 8week of completion of radiation

Secondary

MeasureTime frame
progression free survivalTimepoint: At baseline;radiation side effect compliance and tolerabiltyTimepoint: baseline

Countries

India

Contacts

Public ContactKanchan Dasharthrao Devde

Datta Meghe Institute of higher education and research centre

amolpgi@yahoo.co.in9322978781

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026